Every 10-Q that Mannatech Inc. (MTEX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MTEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MTEX filings page.
Mannatech, Incorporated reported improved results for the three and six months ended June 30, 2026 but continues to face liquidity pressure and a shareholders’ deficit. Net sales were $26.7 million for the quarter (up 3.8%) and $51.6 million for the first half (down 1.3%), with Asia/Pacific contributing about 60% of sales. Gross margin expanded to 76.9% in the quarter as cost of sales declined.
The company generated net income of $1.0 million in Q2 and $2.0 million year-to-date, compared with losses in 2025, aided by $1.7 million in net foreign currency gains over six months. Cash and cash equivalents were $6.0 million and working capital was $2.5 million, while total liabilities of $32.4 million exceeded total assets of $27.5 million, leaving a shareholders’ deficit of $5.0 million. Management disclosed that prior sales declines, operating losses and cost structure misalignment raise substantial doubt about the ability to continue as a going concern and outlined cost cuts, capital discipline, pricing and margin initiatives, and revenue stabilization efforts.
Mannatech, Inc. reported Q1 2026 net sales of $24.9 million, down 6.2% from a year earlier, but swung to net income of $0.95 million versus a prior loss. Gross margin improved to 75.7% on higher pricing and lower inventory charges, and operating cash flow turned positive at $1.1 million. Cash and cash equivalents were $7.0 million with working capital of $1.7 million. However, management discloses conditions that raise substantial doubt about the company’s ability to continue as a going concern and notes noncompliance with a Nasdaq stockholders’ equity requirement. Management is pursuing cost reductions, capital discipline, margin initiatives, and revenue stabilization to address these challenges.
Mannatech (MTEX) filed its Q3 2025 report, showing improved profitability despite softer sales. Net sales were $29.2 million, down 8.1% year over year, but gross margin improved to 76.4% as costs eased. Operating income rose to $2.0 million from $0.9 million. Other income benefited from foreign currency, contributing $0.6 million, and net income reached $1.9 million, or $1.01 per diluted share, versus a loss a year ago.
For the first nine months, net sales were $81.4 million, down 8.4%. The company reported a net loss of $3.9 million, or $2.06 per share, with a $2.6 million realized and unrealized foreign currency loss weighing on results. Cash and cash equivalents were $7.1 million as of September 30, 2025, compared with $11.4 million at year-end, and operating cash flow for the period was negative $2.7 million. Notes payable totaled $2.9 million at a 16% rate, with maturities extended to March 31, 2027.
Asia/Pacific led Q3 with 64.4% of sales, followed by the Americas at 27.1% and EMEA at 8.5%. Shares outstanding were 1,900,930 as of November 4, 2025. Inventory was $11.1 million and deferred revenue tied to loyalty programs ended at $2.3 million.
Mannatech, Inc. reported consolidated net sales of $25.7 million for the three months ended June 30, 2025, down 7.4% from $27.7 million a year earlier; six-month sales were $52.2 million, down 8.6% from $57.1 million. Management attributes the revenue decline principally to weakened economic conditions in certain regions.
The company recorded a net loss of $4.3 million for Q2 2025 (loss per diluted share $2.27) versus a $0.6 million loss in Q2 2024; for the six months it reported a $5.8 million loss compared with six‑month net income of $0.6 million in 2024. A $2.7 million net foreign currency translation loss materially affected results. Cash and cash equivalents totaled $5.525 million (cash plus restricted cash $6.685 million) at June 30, 2025, down from $12.515 million at the period start. Inventories increased to $12.6 million; total assets were $32.8 million and shareholders' equity was $5.964 million at period end.